The organization was founded in 2011 by a group of like-minded medical professionals and thought-leaders in the field who saw a need for an increased commitment to new scientifically-based solutions in dermatology. AID’s goal is to facilitate meaningful interactions and create an ecosystem among a broad range of constituencies with a common interest in bringing innovative products to market that will substantially improve dermatologic health.
AID was conceived of, and is overseen by industry experts including:
The organization is the host of the annual Dermatology Summit, which takes place in January around the JP Morgan Health Conference and provides a unique forum for physicians, entrepreneurs, companies, investors, and other dermatology stakeholders to come together in an environment that fosters an exchange of ideas and provides unparalleled networking opportunities.
More than 340 people attended the 2019 Dermatology Summit held in San Francisco in January, including major pharmaceutical and consumer companies in the dermatology space, emerging players in pharmaceuticals and technology, dermatology service providers, investors and universities. Leadership sponsors included LEO Science and Tech Hub and Pepper Hamilton LLP; Premier sponsors included Dermira, Jefferies, and Sienna Biopharmaceuticals. The Summit also featured an entrepreneurial showcase of companies leading the way in dermatology research and product development, including Cabaletta Bio, Evolus, Kiniksa Pharmaceuticals, MC2 Therapeutics, and Restoration Robotics.
The organization is also a key supporter of the Rutgers University Center for Dermal Research Innovations in Dermatological Science Meeting, which is held annually in the autumn and explores new state-of-the-art scientific work in such areas as topical and transdermal delivery of actives, and skin regeneration.
Nov 14, 2019
AI: It’s not dermatologist vs. machine